SEC Form 4 · accession 0001127602-16-038246
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dwight E Ellingwood
Director
Period of report
Jan 27, 2016
Accepted (ET)
Jan 28, 2016 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,980 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $18.64 | Jan 27, 2016 | A | 8,500 | A | — | Jan 27, 2026 | Common Stock | 8,500 | 8,500 | D |
Explanation of responses
- F1This award vests 25% every 90 days from the date of grant.